Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia

被引：54
|
作者：
Anensen, N. [9 ]
Hjelle, S. M. [9 ]
Van Belle, W. [2 ]
Haaland, I. [9 ]
Silden, E. [9 ]
Bourdon, J-C [3 ]
Hovland, R. [4 ]
Tasken, K. [5 ,6 ]
Knappskog, S. [7 ,8 ]
Lonning, P. E. [7 ,8 ]
Bruserud, O. [9 ]
Gjertsen, B. T. [1 ,9 ]
机构：
[1] Univ Bergen, Haukeland Univ Hosp, Hematol Sect, Dept Internal Med,Inst Med, N-5021 Bergen, Norway
[2] Norut IT, Tromso, Norway
[3] Univ Dundee, Sch Med, Dept Surg & Mol Oncol, Inserm European Associated Lab Inserm, Dundee, Scotland
[4] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway
[5] Univ Oslo, Biotechnol Ctr, Oslo, Norway
[6] Univ Oslo, Ctr Mol Med Norway, Nord EMBL Partnership, Oslo, Norway
[7] Univ Bergen, Sect Oncol, Inst Med, N-5021 Bergen, Norway
[8] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway
[9] Univ Bergen, Inst Med, Hematol Sect, N-5021 Bergen, Norway
来源：
ONCOGENE | 2012年 / 31卷 / 12期
关键词：
p53 protein isoform; p53; beta; gamma; acute myeloid leukemia/NPM1/FLT3-ITD; ACUTE MYELOGENOUS LEUKEMIA; AML; 10; FUNCTIONAL-CHARACTERIZATION; KINASE-ACTIVITY; CHEMOTHERAPY; GENE; NUCLEOPHOSMIN; ACTIVATION; PROGNOSIS; TRANSPLANTATION;
D O I：
10.1038/onc.2011.348
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The wild-type tumor-suppressor gene TP53 encodes several isoforms of the p53 protein. However, while the role of p53 in controlling normal cell cycle progression and tumor suppression is well established, the clinical significance of p53 isoform expression is unknown. A novel bioinformatic analysis of p53 isoform expression in 68 patients with acute myeloid leukemia revealed distinct p53 protein biosignatures correlating with clinical outcome. Furthermore, we show that mutated FLT3, a prognostic marker for short survival in AML, is associated with expression of full-length p53. In contrast, mutated NPM1, a prognostic marker for long-term survival, correlated with p53 isoforms beta and gamma expression. In conclusion, p53 biosignatures contain useful information for cancer evaluation and prognostication. Oncogene (2012) 31, 1533-1545; doi:10.1038/onc.2011.348; published online 22 August 2011
引用
收藏
页码：1533 / 1545
页数：13
相关论文
共 50 条
  • [41] Clinical Implication of Non A Type NPM1 and FLT3 Mutations in Patient with Normal Karyotype Acute Myeloid Leukemia
    Park, B. G.
    Chi, H.
    Park, S.
    Jang, S.
    Park, C.
    Kim, D.
    Lee, J.
    Lee, J.
    Lee, K.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 871 - 871
  • [42] Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy
    Daver, Naval
    Dumlao, Theresa Liu
    Ravandi, Farhad
    Pierce, Sherry
    Borthakur, Gautam
    Pemmaraju, Naveen
    Nazha, Aziz
    Faderl, Stefan
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Cortes, Jorges
    Kantarjian, Hagop
    Quintas-Cardama, Alfonso
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (04): : 435 - 440
  • [43] FLT3 and NPM1 Mutations in Myelodysplastic Syndromes Frequency and Potential Value for Predicting Progression to Acute Myeloid Leukemia
    Bains, Ashish
    Luthra, Rajyalakshmi
    Medeiros, L. Jeffrey
    Zuo, Zhuang
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 135 (01) : 62 - 69
  • [44] Pre-B acute lymphoblastic leukemia presenting with NPM1 and FLT3 mutations
    Khan, Alesia A.
    James, Daniel
    Andresen, Vibeke
    Atkey, Julie
    Bradbury, Rachel
    Cargo, Catherine
    Dillon, Richard
    Gjertsen, Bjorn Tore
    Goldstone, Antony R.
    Leach, Richard
    Lock, Daniel
    Narayanan, Mayanka
    Russell, Nigel
    Verigou, Eleni-Anna
    Green, Simone
    Fielding, Adele K.
    Falini, Brunangelo
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (10) : 2018 - 2022
  • [45] Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations
    Loghavi, Sanam
    Zuo, Zhuang
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Bueso-Ramos, Carlos
    Zhang, Liping
    Singh, Rajesh R.
    Patel, Keyur P.
    Medeiros, L. Jeffrey
    Stingo, Francesco
    Routbort, Mark
    Cortes, Jorge
    Luthra, Rajyalakshmi
    Khoury, Joseph D.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7
  • [46] Simultaneous FLT3, NPM1 and DNMT3A mutations in adult patients with acute myeloid leukemia - case study
    Tripon, Florin
    Crauciuc, George Andrei
    Moldovan, Valeriu George
    Boglis, Alina
    Benedek, Istvan, Jr.
    Lazar, Erzsebet
    Banescu, Claudia
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2019, 27 (03): : 245 - 254
  • [47] Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations
    Sanam Loghavi
    Zhuang Zuo
    Farhad Ravandi
    Hagop M Kantarjian
    Carlos Bueso-Ramos
    Liping Zhang
    Rajesh R Singh
    Keyur P Patel
    L Jeffrey Medeiros
    Francesco Stingo
    Mark Routbort
    Jorge Cortes
    Rajyalakshmi Luthra
    Joseph D Khoury
    Journal of Hematology & Oncology, 7
  • [48] Acute Myeloid Leukemia (AML) with Type A NPM1 Mutation Is More Frequently Associated with FLT3 Mutations Compared with AML with Non-Type A NPM1 Mutations
    Kanagal-Shamanna, R.
    Singh, R. R.
    Routbort, M. J.
    Ravandi, F.
    Kantarjion, H.
    Medeiros, L. J.
    Luthra, R.
    Patel, K. P.
    MODERN PATHOLOGY, 2014, 27 : 354A - 354A
  • [49] Blasts with folded nuclei: A histopathologic finding in myeloid leukemia cutis with NPM1 and FLT3 mutations
    Han, Shannon
    Patel, Tejesh
    Garcia, Marie-Laure
    Tirado, Mariantonieta
    JOURNAL OF CUTANEOUS PATHOLOGY, 2024, 51 (02) : 130 - 134
  • [50] Prognostic Impact of Concurrent DNMT3A, FLT3 and NPM1 Gene Mutations in Acute Myeloid Leukemia Patients
    Abd Elrhman, Heba Allah E.
    El-Meligui, Yomna M.
    Elalawi, Saffaa M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (12): : E960 - E969
12345